News & Event Trading
News and event trading is a short-term style that seeks to profit from the price dislocation around a discrete, scheduled or unscheduled catalyst — earnings, FDA/PDUFA decisions, M&A announcements, guidance changes, analyst actions, economic data, or breaking headlines. Its defining feature is that a known information event compresses a large amount of price discovery into a tiny window, producing volatility, gaps, and volume far above baseline. The core tension is that the very thing that creates opportunity (a sudden, large move) also destroys the trader's two normal edges: there is rarely time to react before institutions and algorithms have repriced the stock, and the outcome of the catalyst itself is frequently unknowable in advance. The skill is therefore less about predicting the news and more about trading the reaction to the news — fading overreactions, riding confirmed drift, or sizing for binary risk.
The setups
Event trades fall into a few recurring archetypes a short-term trader keys on:
- Earnings gap continuation ("gap-and-go" / drift). A stock gaps on a genuine earnings surprise with heavy volume, holds the gap, and continues in the surprise direction over the following 2–10 sessions. The classic intraday trigger is a break of the first 5-minute (or 15-minute) opening-range high (longs) or low (shorts), with a stop below the opening-range low / VWAP and a 2:1 minimum reward-to-risk (Tradewink). This is the retail-tradeable expression of the academic post-earnings-announcement drift (PEAD) anomaly.
- Gap fade / reversion. When a gap is driven by sentiment rather than a fundamental change — a small surprise, an already-extended pre-event run, or a "common" gap in a quiet name — the move tends to fill. Fades are most reliable on non-earnings gaps; breakaway gaps on real catalysts should not be faded blindly (Capital.com).
- Binary-event run-up ("buy the rumor"). Biotech PDUFA/clinical catalysts produce a documented pre-event run-up — typically beginning ~4–8 weeks out and adding (per practitioner sources, not peer-reviewed) on the order of 20–40% — followed by "sell the news" on the announcement, even on good outcomes, as early holders exit (BiopharmaWatch). The lower-risk play is to capture the run-up and exit before the binary print.
- Merger arbitrage spread. After a deal is announced, the target trades at a discount to the offer; the spread is compensation for deal-break risk. Long target (and short acquirer in stock deals) captures the spread on close (Wikipedia: Risk arbitrage). This is primarily an institutional, slow-clock event strategy.
The connecting tool across earnings setups is the options-implied (expected) move: roughly 0.85 × the front-month at-the-money straddle gives the market's one-standard-deviation expected reaction (Resonanz Capital). A reaction smaller than the implied move suggests muted continuation; a reaction larger than implied on big volume is the strongest drift signal.
How it's used in practice
A disciplined event trader works the calendar, not the headline. The decision-useful conditions:
1. Trade reaction, not prediction. Do not pre-position into a binary print expecting to guess the result. Let the catalyst hit, then trade the established direction with confirmation. 2. Demand a surprise and a confirming reaction. Drift is real only when the reported number genuinely deviates from consensus and price + volume confirm in that direction. A beat that sells off is a failed catalyst — respect the tape over the headline. 3. Use the opening range as the trigger. The first 30–60 minutes carry the heaviest participation; entering on the opening-range break (not the gap itself) filters out the immediate algorithmic fade (Crosstrade gap-and-go). 4. Anchor stops to structure. Below the gap-day low, opening-range low, or VWAP. The drift thesis is invalidated if the stock closes back below the earnings-gap open within the first day or two — exit there. 5. Size for the gap, not the average day. Because event names skip levels, position size must assume the stop will slip. Binary biotech/FDA names can lose 40–80% on a CRL overnight (BiopharmaWatch); size so a worst-case gap is survivable. 6. Hold duration matches the setup. Earnings drift swings typically run 2–5 days (some sources cite up to ~10); run-up plays are weeks; merger arb is months.
Adoption, debate & evidence
Event trading is widely practiced and the underlying drift is one of the best-documented anomalies in finance. PEAD was first documented by Ball & Brown (1968) and reinforced by Bernard & Thomas (1989/1990), who attributed it to investors underreacting — naively treating earnings as a seasonal random walk (Wikipedia: PEAD). Bernard & Thomas reported a zero-investment portfolio (long high-SUE / short low-SUE) earning roughly 8–9% over a quarter (≈35% annualized before costs), with the top–bottom SUE spread positive in 41 of 48 quarters from 1974–1985. A 2020 review reports per-study abnormal returns in the often-cited ~2.6%–9.4% range, though sources disagree on whether that figure is per-quarter or per-annum, so the number is best read as order-of-magnitude rather than precise. Crucially, the measured magnitude has decayed over time — from roughly 5% in the 1980s–90s to ~3% or lower by the late 2010s — consistent with arbitrage eroding the edge (Wikipedia: PEAD). It nonetheless contradicts semi-strong efficiency and has persisted for decades.
The honest caveats: (1) the academic edge is a diversified, cross-sectional portfolio result, not a guarantee on any single name — individual stocks routinely reverse. (2) Practitioner "beat the implied move" and "run-up" percentages (e.g. that stocks stay inside the expected move ~70–75% of the time, slightly above the theoretical 68% because pre-event IV is inflated) come from trading sites and brokerages, not peer review, and should be treated as folklore-grade (EarningsWatcher). (3) Most importantly for a retail/swing trader: the initial repricing is captured by HFT and institutions in microseconds; retail order flow reacts on a delay, eating slippage exactly when spreads are widest (Autochartist on HFT). The realistically capturable retail edge is the drift over days, not the first-second gap.
Strengths & limitations
Strengths: catalysts create the cleanest risk/reward setups in trading — direction, magnitude, and timing are partly knowable in advance, volume is high, and the post-event drift gives a multi-day, swing-friendly window. Limitations: binary outcomes (FDA, deal-break, surprise misses) can gap straight through any stop, making it the style most prone to single-event ruin; pre-event positioning is closer to gambling than edge; and the speed disadvantage is structural. The #1 misuse is holding a concentrated, full-size position through a binary print on conviction — that is not event trading, it is uncompensated lottery risk. The professional version waits for the print, demands confirmation, and sizes for the gap.
Sources
- Ball & Brown / Bernard & Thomas via Wikipedia: Post–earnings-announcement drift
- A review of the Post-Earnings-Announcement Drift — ScienceDirect (abnormal-return ranges — period basis, quarter vs annum, is reported inconsistently across summaries; treat the 2.6%–9.4% figure as order-of-magnitude)
- How to Trade Earnings Reports — Tradewink (gap-and-go entry/stop rules)
- Gap-and-go strategy — Crosstrade and Gap trading — Capital.com (fade vs continuation)
- Biotech Catalyst Trading — BiopharmaWatch (PDUFA run-up, binary downside) — practitioner source, percentages unverified by peer review
- Risk arbitrage — Wikipedia (merger-arb spread / deal-break)
- Options Straddles and Earnings Move Estimates — Resonanz Capital (0.85 × ATM straddle implied move)
- Earnings Expected Moves — EarningsWatcher (~70–75% inside implied move) — practitioner source
- HFT vs retail — Autochartist (speed disadvantage)
Disputes flagged: PEAD's existence is robust and peer-reviewed, but its magnitude is both contested and decaying over time (figures vary by study, period basis, and decade); the retail-capturable slice is smaller still. The biotech run-up / implied-move hit-rate percentages are practitioner folklore, not academic findings.